Thursday, April 17, 2025

The US FDA cleared Neuralink rival Precision Neuroscience in late March 2025 to offer a less invasive brain implant; the device contains 1,024 metal electrodes (Ike Swetlitz/Bloomberg)

Ike Swetlitz / Bloomberg:
The US FDA cleared Neuralink rival Precision Neuroscience in late March 2025 to offer a less invasive brain implant; the device contains 1,024 metal electrodes  —  One of the co-founders of Elon Musk's Neuralink Corp. is building a different kind of brain implant.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New York City-based Current, which manages a consumer fintech platform, raised an $80M Series E at a $1.5B valuation led by Springcoast Partners (FinSMEs)

FinSMEs : New York City-based Current, which manages a consumer fintech platform, raised an $80M Series E at a $1.5B valuation led by Spr...